pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
  1. pharmadog
  2. ›drugs
  3. ›METHYLPREDNISOLONE
drug
save

METHYLPREDNISOLONE

Marketedupdated 3mo ago
by GeneYork Pharmaceuticals Group LLC
Approved
community read0 votes

🐶 often sniffed alongside

top 8
  • tagApproval254 co-mentions · 127 sources
  • drugMEDROL231 co-mentions · 131 sources
  • drugSOLU-MEDROL96 co-mentions · 48 sources
  • drugDEPO-MEDROL75 co-mentions · 44 sources
  • drugmethylprednisolone sodium succinate48 co-mentions · 48 sources
  • drugMETHYLPREDNISOLONE ACETATE44 co-mentions · 44 sources
  • tagSmall Molecule37 co-mentions · 37 sources
  • companyGreenstone LLC2 co-mentions · 1 sources

all catalysts(0)

nothing on the calendar yet

Trials studying METHYLPREDNISOLONE

  • phase4A Study of Teprotumumab N01 in Subjects With Active Thyroid Eye Diseaserecruitingn=92
  • phase3A Study to Evaluate Zilovertamab Vedotin (MK-2140) Combination With Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) in Participants With Previously Untreated DLBCL (MK-2140-010)recruitingn=1,046
  • phase3A Study to Evaluate the Efficacy and Safety of Obinutuzumab in Participants With ISN/RPS 2003 Class III or IV Lupus Nephritisactive not recruitingn=271
  • phase2A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Obinutuzumab in Adolescents With Active Class III or IV Lupus Nephritis and the Safety and PK of Obinutuzumab in Pediatric Participantsrecruitingn=40
  • phase3Privosegtor Investigation in Optic Neuropathies Efficacy Evaluation Researchrecruitingn=210
  • phase3A Study to Investigate the Efficacy and Safety of Frexalimab Versus Tacrolimus in Adults Undergoing Kidney Transplantationrecruitingn=526
  • phase3A Study of BGB-16673 Compared to Investigator's Choice in Participants With Relapsed/Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Previously Exposed to Covalent Bruton Tyrosine Kinase (BTK) Inhibitorsrecruitingn=150
  • phase2Study of ASP2957 in Male Participants With X-linked Myotubular Myopathy Who Need Ventilatorsrecruitingn=9
more trials →

News(1)

  • Opinion: The U.S. pharmaceutical supply chain problem is not about China
    The national security framing of the discussion around pharmaceutical supply chain vulnerabilities is a distraction, writes Pooja Yerramilli.
    stat · 24d ago
brand
METHYLPREDNISOLONE
generic
METHYLPREDNISOLONE
indication
Acquired (Autoimmune) Hemolytic Anemia
phase
marketed
Data sources
ClinicalTrials.gov
last refreshed 10m ago
Found something off?
🐶 something off?

Report a data issue

Tell Bork what looks wrong — wrong sponsor, stale phase, mislinked ticker, anything. We’ll triage and fix.

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?